Net Income (TTM) Chart

View Net Income (TTM) for RVMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (TTM) Chart
Start Trial

Historical Net Income (TTM) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -1.768B
March 31, 2026 -1.372B
December 31, 2025 -1.131B
September 30, 2025 -960.98M
June 30, 2025 -812.06M
March 31, 2025 -697.51M
December 31, 2024 -600.09M
September 30, 2024 -567.06M
June 30, 2024 -519.21M
March 31, 2024 -484.27M
December 31, 2023 -436.37M
September 30, 2023 -331.34M
June 30, 2023 -296.23M
March 31, 2023 -259.16M
Date Value
December 31, 2022 -248.70M
September 30, 2022 -244.87M
June 30, 2022 -224.48M
March 31, 2022 -207.56M
December 31, 2021 -187.09M
September 30, 2021 -168.62M
June 30, 2021 -142.90M
March 31, 2021 -125.82M
December 31, 2020 -108.16M
September 30, 2020 -88.55M
June 30, 2020 -74.15M
March 31, 2020 -57.05M
December 31, 2019 -47.66M
September 30, 2019 -44.41M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (TTM) Range, Past 5 Years

View Net Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (TTM) Benchmarks

View Net Income (TTM) Benchmarks
Start Trial
Tango Therapeutics, Inc. -123.72M
Erasca, Inc. -287.22M
Moderna, Inc. -3.151B
Arrowhead Pharmaceuticals, Inc. -272.12M
Intellia Therapeutics, Inc. -399.98M